Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc ADR (NQ: AZN )

83.05 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 260
Open 83.05
Bid (Size) 82.59 (9)
Ask (Size) 82.66 (9)
Prev. Close 83.05
Today's Range 83.05 - 83.05
52wk Range 60.47 - 87.67
Shares Outstanding N/A
Dividend Yield 1.12%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novel computational pathology-based TROP2 biomarker for datopotamab deruxtecan was predictive of clinical outcomes in patients with non-small cell lung cancer in TROPION-Lung01 Phase III trial
From AstraZeneca
Via Business Wire
3 Market-Beating Stocks to Buy for Less Than $100
These stocks are all up more than 20% this year. 
Via The Motley Fool

Performance

YTD
+21.42%
+21.42%
1 Month
+2.29%
+2.29%
3 Month
+3.54%
+3.54%
6 Month
+22.73%
+22.73%
1 Year
+24.70%
+24.70%

More News

Read More
AstraZeneca In Trouble For Employee Detentions in China Over Illegal Activities
Via Benzinga
Topics Law Enforcement
Exposures Legal
AstraZeneca Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Reasonable Growth, Debt Levels, and a High ROIC Make ASTRAZENECA PLC-SPONS ADR (NASDAQ:AZN) Appealing to Quality Investors.
Via Chartmill
Is NASDAQ:AZN a Suitable Choice for Quality Investing?
Via Chartmill
EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
Via Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
Via Benzinga
Topics Economy
Exposures Interest Rates
AstraZeneca advances ambition to improve standards of care in multiple cancer types at WCLC and ESMO 2024
From AstraZeneca
Via Business Wire
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
Via Investor's Business Daily
Biotech And Life Science Sector Update Summer Of 2024
Via Talk Markets
AstraZeneca Threatens To Move Vaccine Production Amid Reduced State Support
Via Benzinga
Biotech Bull Market: 3 Ways To Play It
Via Talk Markets
Topics Economy
Exposures Interest Rates
Ozempic And Wegovy Linked to Increased Suicidal Thoughts In Observational Study, But Results Are Contested
Via Benzinga
Johnson & Johnson Strikes $1.7B Deal To Acquire Heart-Tech Innovator V-Wave
Via Benzinga
Exposures Product Safety
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer
Via Benzinga
Exposures Product Safety
IMFINZI® (durvalumab) approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery
From AstraZeneca
Via Business Wire
Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations
Via Investor's Business Daily
IMFINZI® (durvalumab) granted Priority Review and Breakthrough Therapy Designation for patients with limited-stage small cell lung cancer in the US
From AstraZeneca
Via Business Wire
AstraZeneca's $578M Vaccine Plant In Doubt As UK Government Cuts Funding
Via Benzinga
Defying the Market: 3 Mega-Cap Stocks Soaring to New Highs
Via MarketBeat
Topics ETFs
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
Via InvestorPlace
Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
Via Benzinga
Exposures COVID-19
New European Regulations Could Hinder Rare Disease Treatments, Pharma Industry Raises Concerns Over Stricter Clinical Trial Rules
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.